Immunologic considerations for the development of conjugate vaccines.
Garner
C V
CV
Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Pier
G B
GB
D000328:Adult; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006241:Haptens / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007223:Infant; D008211:Lymphocyte Cooperation; D051379:Mice; D009345:Neisseria meningitidis / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014121:Toxoids / Q000008:administration & dosage / Q000276:immunology; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D006241:Haptens; D011135:Polysaccharides, Bacterial; D014121:Toxoids; D014612:Vaccines; D014614:Vaccines, Synthetic